QQ客服 官方微博 反馈留言

	Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure
	Li, Jian; Zhang, Wei; Kang, Wen-Ying; Cao, Xin-Xin; Duan, Ming-Hui; Zhou, Dao-Bin
	2012
卷号	53期号:12页码:2527-2529
ISSN号	1042-8194
DOI	10.3109/10428194.2012.690515
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6722155
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Jian,Zhang, Wei,Kang, Wen-Ying,et al. Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure[J],2012,53(12):2527-2529.
APA	Li, Jian,Zhang, Wei,Kang, Wen-Ying,Cao, Xin-Xin,Duan, Ming-Hui,&Zhou, Dao-Bin.(2012).Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.,53(12),2527-2529.
MLA	Li, Jian,et al."Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure".53.12(2012):2527-2529.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。